Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...
LONDON, Dec 10 (Reuters) - Roche (ROG.S), opens new tab said on Wednesday its experimental oral drug giredestrant reduced the risk of breast cancer recurrence by 30% compared with standard endocrine ...
The most commonly used and prescribed birth control pill in the U.S. was classified by the International Agency for Research on Cancer (IARC) at the World Health Organization (WHO) as carcinogenic. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback